Call for Papers Trends in Immunotherapy
Special Issue Theme Topic: Research Progress in Immunotherapy in China Issue: Volume 5 Issue 2.1, 2021 Key topics for submissions include but are not limited to: 1. Cancer immunotherapy 2. Targeted therapy and tumor microenvironment 3. Immune dysregulation, skin barrier dysfunction 4. Chemoimmunotherapy 5. Antibodies 6. Immunomodulators, inhibitors and intensifiers 7. Therapeutic method for auto-immune disorder 8. Efficacy of drug immunotherapy 9. Allergy disorder and immunotherapy 10. Immunotherapy cell-products 11. Immuno-modulatory effects of natural products 12. Vaccine development and application 13. Cytokines application 14. Wound healing TI publishes original research articles, review articles, editorials, mini-review articles, case reports, commentaries, correspondence articles, database articles, perspective articles, short reports, etc. Preliminary studies, pre-clinical and clinical investigative reports are welcomed. Submission Submission deadline: 15 October 2021 for Volume 5 Issue 2.1, 2021 The papers will be published under such circumstances: 1. The field of manuscripts meets the requirements of the journal. 2. As part of the standard procedure, the manuscripts will be sent to two members of its Board of Reviewing Editors, who recommended that it go out for peer review and pass the review. 3. The papers submitted from June 16, 2021 to October 15, 2021. Online Submission For abstract submission send directly by mail to: reviewer@enpress-publisher.com For full paper submit online at: https://systems.enpress-publisher.com/index.php/ti/about/submissions#onlineSubmissions
Editorial Board Editor-in-Chief Prof. Dr. Fukumi Furukawa President Takatsuki Red Cross Hospital, Japan E-mail: ffurukawa@takatsuki.jrc.or.jp Associate Editors Prof. Hiroki Yamaue Wakayama Medical University Japan Prof. Toshikazu Kondo Wakayama Medical University Japan Indexing Trends in Immunotherapy has been indexed in database, such as: Scopus, Google Scholar, Crossref, CNKI Scholar, Worldcat. Trends in Immunotherapy aims to be indexed by PubMed, ProQuest, MEDLINE and Science Citation Index (SCI). |
This site is licensed under a Creative Commons Attribution 4.0 International License.